Proteomic Profile in Women With Endometriosis (PROTEO-ENDO) Study

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

In this prospective case control study a total of 66 women (33 women with endometriosis) and (33 healthy women) will be recruited. The main objective of the study is to investigate the proteomic profile of menstrual blood in women with endometriosis compared to controls. Additionally, differentially expressed proteins will be investigated across different stages, clinical presentations, and subtypes of endometriosis

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• Endometriosis group. are women aged 18-45 years old Laparoscopy with histologically confirmed diagnosis of endometriosis

• Healthy group are women between 18-45 years old self reported no known history of medical \& surgical diseases and no any sign of endometriosis related symptoms

Locations
Other Locations
Hong Kong Special Administrative Region
The Chinese University of Hong Kong, Prince of Wales Hospital
RECRUITING
Hong Kong
Contact Information
Primary
Chi Chiu Wang, MD, PhD
ccwang@cuhk.edu.hk
(852) 35054267
Backup
Getnet Gedefaw Azeze, MSc
gedefawget@link.cuhk.edu.hk
(852) 51724303
Time Frame
Start Date: 2023-11-15
Estimated Completion Date: 2026-02-15
Participants
Target number of participants: 66
Treatments
Endometriosis
Women suggested endometriosis by clinical presentations \& imaging and scheduled for surgical treatment (laparotomy/laparoscopy) at the age of 18-45 years having regular menstrual cycles will be recruited. Finally laparoscopy and histology confirmed endometriosis cases will be eligible for the final analysis.
Healthy groups
Control subjects at the age of 18-45 years, who have regular menstrual cycles and self-reported no history suggestive of a diagnosis of endometriosis will be recruited.
Related Therapeutic Areas
Sponsors
Leads: Chinese University of Hong Kong

This content was sourced from clinicaltrials.gov